Do antiplatelets and anticoagulants have an impact on the clinical outcomes of robotic ventral hernia repair?

Kudsi O. Y., Kaoukabani G., Bou-Ayash N., Gokcal F.

American Journal of Surgery, cilt.226, sa.2, ss.213-217, 2023 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 226 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1016/j.amjsurg.2023.04.007
  • Dergi Adı: American Journal of Surgery
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Biotechnology Research Abstracts, CAB Abstracts, CINAHL, EMBASE
  • Sayfa Sayıları: ss.213-217
  • Anahtar Kelimeler: Anticoagulants, Antiplatelets, Antithrombotics, Robotic ventral hernia repair
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Background: We sought to study the impact of antithrombotics(antiplatelets and anticoagulants) on robotic ventral hernia repair(RVHR). Methods: RVHR cases were divided into antithrombotic (AT) (−) and AT (+) groups. After comparing both groups, a logistic regression analysis was performed. Results: 611 patients had no AT-medication. The AT(+) group had 219 patients of which 153 were only on antiplatelets, 52 only on anticoagulants, and 14(6.4%) patients on both antithrombotics. Mean age, American Society of Anesthesiology scores, and comorbidities were significantly higher in the AT(+) group. Intraoperative blood loss was greater in the AT(+) group. Postoperatively, the AT(+) group had greater rates of Clavien-Dindo grade-II and IV-a complications(p=0.001, and p=0.013, respectively), and postoperative hematomas(p=0.013). Mean follow-up was greater than 40 months. Age[Odds Ratio(OR): 1.034] and anticoagulants(OR: 3.121) were associated with increased bleeding-related events. Conclusion: There were no associations between maintained antiplatelet therapy and postoperative bleeding-related events in RVHR whereas age and anticoagulants had the highest association.